Target intelligence / Profile preview

Bacterial 23S ribosomal RNA (domains II and V) (23S rRNA (domains II and V))

Target
23S rRNA (domains II and V)
Molecular classification
Ribosomal RNA, Ribozyme, Enzyme, Other
01

Overview

The bacterial 50S ribosomal subunit, specifically domains II and V of the 23S ribosomal RNA (rRNA), serves as the functional core for protein synthesis in bacteria (Wilson, 2014). Domain V contains the peptidyl transferase center (PTC), which catalyzes peptide bond formation, while domain II forms part of the nascent peptide exit tunnel (NPET) (Dunkle et al., 2010). This region is the primary binding site for several major classes of antibiotics, including macrolides, lincosamides, oxazolidinones, and pleuromutilins (Arenz & Wilson, 2016). These drugs exert their antimicrobial effects by sterically hindering the elongation of the peptide chain or by interfering with the positioning of tRNA substrates within the PTC (StatPearls). Because of the high conservation of these rRNA domains across bacterial species, they are versatile targets for broad-spectrum and narrow-spectrum antibiotics used to treat respiratory, skin, and systemic infections. However, the structural similarity between bacterial 23S rRNA and human mitochondrial rRNA can lead to off-target effects and toxicity, such as myelosuppression (Long & Vester, 2012). Resistance often arises through point mutations in the rRNA or through the action of methyltransferases that modify specific nucleotides within these domains.

Other names
Peptidyl transferase centerPTC50S ribosomal RNALarge ribosomal subunit RNA23S rRNA
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the peptidyl transferase center (PTC) or the nascent peptide exit tunnel (NPET) within the 50S subunit, thereby blocking peptide bond formation or the progression of the growing polypeptide chain (Wilson, 2014; StatPearls).

03

Biological functions

Protein synthesisPeptidyl transferase activityTranslationOther
04

Disease associations

Infection
05

Safety considerations

Mitochondrial protein synthesis inhibition (Long & Vester, 2012)Myelosuppression (e.g., anemia, thrombocytopenia)Optic and peripheral neuropathyGastrointestinal distressDevelopment of multi-drug resistance (e.g., MRSA, VRE)
06

Interacting drugs

Erythromycin

10 more in the full profile.

07

Biomarkers

23S rRNA A2058/A2059 mutations (Wilson, 2014)erm gene-mediated rRNA methylation (StatPearls)cfr gene-mediated rRNA methylation (Long & Vester, 2012)rplC or rplD ribosomal protein mutations

Beyond the preview

Go deeper on Bacterial 23S ribosomal RNA (domains II and V) (23S rRNA (domains II and V)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 23S ribosomal RNA (domains II and V) (23S rRNA (domains II and V)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call